首页> 外文会议>Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai >Current Trend of Pediatric Renal Replacement Therapy in Japan
【24h】

Current Trend of Pediatric Renal Replacement Therapy in Japan

机译:日本儿科肾置换疗法的当前趋势

获取原文

摘要

Background: End-stage renal disease (ESRD) in children is considered a rare but serious condition. Information on the epidemiology, demographics, treatment modality at the start of renal replacement therapy (RRT), and mortality of pediatric patients with ESRD is essential for a better understanding of this disease. Additionally, international comparisons of this information on pediatric patients with ESRD may improve outcomes in these children. Here, I will provide information on epidemiological and demographic characteristics of pediatric Japanese patients with ESRD and the current trend of pediatric RRT in Japan. Summary: The Japanese Society for Pediatric Nephrology (JSPN), in collaboration with the Japanese Society for Dialysis Therapy (JSDT) and the Japanese Society for Clinical Renal Transplantation (JSCRT), conducted a cross-sectional nationwide survey in 2012 to update information on the incidence, primary renal disease, initial treatment modalities, and survival in pediatric Japanese patients with ESRD aged less than 20 years during the period 2006-2011. The average incidence of ESRD was 4.0 per million age-related populations, much lower than in other high-income countries. Congenital anomalies of the kidney and urinary tract were the most common cause of ESRD, present in 39.8% of these patients, which was similar to the data reported from USA, Europe, and Australia and New Zealand. While the previous Japanese survey in 1998 reported that only 1 patient (0.9%) underwent preemptive transplantation, the JSPN ESRD Survey 2012 found that 22.3% of patients were initially treated by preemptive transplantation.Thus, the use of preemptive transplantation as the initial treatment modality for Japanese children with ESRD is comparable to that for ESRD children in the USA, Europe, and Australia and New Zealand. The 5-year survival rate of Japanese children with ESRD who received RRT was 91.5%, which was similar to the rates observed in other high-income countries. Key Messages: The incidence of ESRD is lower in Japanese children than in children in other high-income countries. There has been a marked increase in the use of preemptive transplantation as the initial treatment modality for pediatric Japanese patients with ESRD.
机译:背景:儿童的末期肾病(ESRD)被认为是一种罕见但严重的病情。关于流行病学,人口统计学,治疗方式在肾脏替代疗法开始(RRT)的信息,以及对ESRD的儿科患者的死亡率对于更好地了解这种疾病至关重要。此外,对具有ESRD的儿科患者的国际信息的国际比较可能会改善这些儿童的结果。在这里,我将提供关于ESRD小儿日本患者的流行病学和人口特征的信息和日本儿科RRT的当前趋势。摘要:日本儿科肾脏学会(JSPN),与日本透析治疗(JSDT)和日本临床肾移植(JSCRT)合作,2012年进行了横断面的全国范围调查,以更新有关的信息发病率,原发性肾病,初始治疗方式,儿科日本患者的生存患者在2006 - 2011年期间少于20年。 ESRD的平均发病率为4.0百万与年龄相关的人群,远低于其他高收入国家。肾脏和泌尿道的先天性异常是ESRD最常见的原因,这些患者的39.8%,这与来自美国,欧洲和澳大利亚和新西兰报告的数据类似。虽然1998年以前的日本调查报告说,只有1名患者(0.9%)的抢先移植,2012年的JSPN ESRD调查显示,22.3%的患者最初通过先发制人的移植治疗。本,使用先发型移植作为初始治疗方式对于日本人的ESRD,与美国,欧洲和澳大利亚和新西兰的ESRD儿童相当。获得RRT的ESRD的日本儿童的5年生存率为91.5%,与其他高收入国家的率类似。关键信息:日本儿童的ESRD的发生率比其他高收入国家的儿童低于儿童。使用先发型移植作为ESRD小儿日本患者的初始治疗方式有明显增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号